AIDing cancer treatment: Reducing AID activity via HSP90 inhibition.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26151367)

Published in Eur J Immunol on July 07, 2015

Authors

Stefan Rebhandl1,2, Roland Geisberger1,2

Author Affiliations

1: Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.
2: Salzburg Cancer Research Institute, Salzburg, Austria.

Articles cited by this

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell (2000) 20.83

HSP90 and the chaperoning of cancer. Nat Rev Cancer (2005) 11.98

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell (2000) 9.99

Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature (2010) 8.84

DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell (2008) 8.62

Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem (2007) 6.92

Two levels of protection for the B cell genome during somatic hypermutation. Nature (2008) 5.32

Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res (2012) 4.01

AID is required for c-myc/IgH chromosome translocations in vivo. Cell (2004) 3.89

Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med (2007) 3.70

Constitutive expression of AID leads to tumorigenesis. J Exp Med (2003) 3.16

AID is required for germinal center-derived lymphomagenesis. Nat Genet (2007) 2.79

The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell (2009) 2.42

Estrogen directly activates AID transcription and function. J Exp Med (2009) 2.37

Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med (2008) 1.80

Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol (2009) 1.64

Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene (2007) 1.43

17 AAG for HSP90 inhibition in cancer--from bench to bedside. Curr Mol Med (2009) 1.40

Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90. J Exp Med (2010) 1.33

Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer. Gastroenterology (2010) 0.95

Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells. Proc Natl Acad Sci U S A (2013) 0.90

AID/APOBEC deaminases and cancer. Oncoscience (2015) 0.89

HSP90 inhibitors decrease AID levels and activity in mice and in human cells. Eur J Immunol (2015) 0.88

AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells. Eur J Immunol (2014) 0.84